Skip to main content
. Author manuscript; available in PMC: 2021 Oct 6.
Published in final edited form as: Mol Pharm. 2017 Feb 3;14(5):1384–1394. doi: 10.1021/acs.molpharmaceut.6b01005

Table 1.

Copolymerization of HPMA with MA-GFLG–PTXa,b,c

[CTA]/[I] initiator solvent temp (°C) time (h) Mw (kDa) PDI yield (%) drug% (wt)
P-1 2.5 V65 DMSO/H+ 50 24 51.8 1.10 35 7.2
P-2 1.25 V65 DMSO/H+ 50 24 66.3 1.17 39 6.6
P-3 1.25 VA044 DMSO/H2O 3:1 (v/v) 40 48 105 1.12 81 6.6
a

200 mg scale: 156 mg HPMA/44 mg MA-GFLG–PTX; PTX 3% molar ratio in feed.

b

Monomer concentration 16.6% (wt).

c

[M]/[CTA] = 1106.